NextPlat Corp (NASDAQ:NXPL) Short Interest Update

NextPlat Corp (NASDAQ:NXPL) was the target of a significant increase in short interest in December. As of December 15th, there was short interest totalling 54,000 shares, an increase of 1,762.1% from the November 30th total of 2,900 shares. Approximately 0.4% of the company’s stock are sold short. Based on an average daily volume of 119,400 shares, the days-to-cover ratio is currently 0.5 days.

Institutional Trading of NextPlat

A hedge fund recently bought a new stake in NextPlat stock. Omnia Family Wealth LLC purchased a new position in shares of NextPlat Corp (NASDAQ:NXPL) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 93,429 shares of the company’s stock, valued at approximately $132,000. Omnia Family Wealth LLC owned approximately 0.49% of NextPlat at the end of the most recent quarter. 1.30% of the stock is currently owned by hedge funds and other institutional investors.

NextPlat Stock Up 6.1 %

NextPlat stock traded up $0.07 during mid-day trading on Thursday, reaching $1.19. The company’s stock had a trading volume of 107,337 shares, compared to its average volume of 277,754. The company has a debt-to-equity ratio of 0.04, a quick ratio of 3.04 and a current ratio of 3.70. NextPlat has a 12 month low of $0.71 and a 12 month high of $2.68. The business’s 50 day simple moving average is $1.03 and its 200 day simple moving average is $1.13. The company has a market capitalization of $30.86 million, a price-to-earnings ratio of -1.75 and a beta of 0.85.

About NextPlat

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.